Skip to main content

Invasive Candidiasis in Surgical Patients

  • Chapter
  • First Online:
Infections in Surgery

Abstract

Invasive and disseminated Candida infections have become a major source of morbidity and mortality in neutropenic and nonneutropenic surgical intensive care patients. The incidence of Candida has increased: it is now the fourth most often isolated pathogen in bloodstream infections. After extended intraabdominal surgery and especially in emergency intraabdominal infection the abdomen is the predominant focus for candida infection. Intraabdominal candidiasis (IAC) is the predominant type of invasive candidiasis after candidemia. IAC is associated with mortality rates around 25–60%. Some studies have demonstrated almost a double mortality rate (48% versus 28%) in critically ill surgical patients with nosocomial fungal peritonitis compared to those without fungal infection. The diagnosis of postoperative candida infections is difficult because clinical signs and laboratory findings are unspecific. The decisive factors for a favorable outcome of infected patients are early diagnosis, adequate source control, as well as a prompt and appropriate anti-infective therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Bassetti M, Giacobbe DR, Vena A, Trucchi C, Ansaldi F, Antonelli M, Adamkova V, Alicino C, et al. Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project. Crit Care. 2019 Jun 14;23(1):219.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Bassetti M, Righi E, Ansaldi F, Merelli M, Scarparo C, Antonelli M, Garnacho-Montero J, Diaz-Martin A, Palacios-Garcia I, et al. A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality. Intensive Care Med. 2015 Sep;41(9):1601–10.

    Article  PubMed  Google Scholar 

  3. Vincent JL, Anaissie E, Bruining H, Demajo W, el-Ebiary M, Haber J, Hiramatsu Y, Nitenberg G, Nyström PO, et al. Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med. 1998 Mar;24(3):206–16.

    Article  CAS  PubMed  Google Scholar 

  4. Bongomin F, Gago S, Oladele RO, Denning DW. Global and multi-national prevalence of fungal diseases-estimate precision. J Fungi (Basel). 2017 Oct 18;3(4):pii: E57.

    Article  Google Scholar 

  5. Denning DW. Global fungal burden. Mycoses. 2013;56:13.

    Article  Google Scholar 

  6. Limper AH, Adenis A, Le T, Harrison TS. Fungal infections in HIV/AIDS. Lancet Infect Dis. 2017;17(11):e334–43.

    Article  PubMed  Google Scholar 

  7. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D. Sepsis occurrence in acutely ill patients investigators. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006 Feb;34(2):344–53.

    Article  PubMed  Google Scholar 

  8. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) study. EPIC International Advisory Committee. JAMA. 1995 Aug 23–30;274(8):639–44.

    Article  CAS  PubMed  Google Scholar 

  9. Miguel N, León MA, Ibáñez J, Díaz RM, Merten A, Gahete F. Sepsis-related organ failure assessment and withholding or withdrawing life support from critically ill patients. Crit Care. 1998;2(2):61–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Aguilar G, Delgado C, Corrales I, Izquierdo A, Gracia E, Moreno T, Romero E, Ferrando C, Carbonell JA, Borrás R, Navarro D, Belda FJ. Epidemiology of invasive candidiasis in a surgical intensive care unit: an observational study. BMC Res Notes. 2015;8:491.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Sganga G. Clinical aspects of invasive candidiasis in the surgical patient. Drugs. 2009;69(Suppl 1):29–32.

    Article  PubMed  Google Scholar 

  12. Haltmeier T, Inaba K, Effron Z, Dollbaum R, Shulman IA, Benjamin E, Lam L, Demetriades D. Candida score as a predictor of worse outcomes and mortality in severely injured trauma patients with positive Candida cultures. Am Surg. 2015 Oct;81(10):1067–73.

    Article  PubMed  Google Scholar 

  13. Enoch DA, Yang H, Aliyu SH, Micallef C. The changing epidemiology of invasive fungal infections. Methods Mol Biol. 2017;1508:17–65. Review.

    Article  CAS  PubMed  Google Scholar 

  14. Blyth DM, Mende K, Weintrob AC, Beckius ML, Zera WC, Bradley W, Lu D, Tribble DR, Murray CK. Resistance patterns and clinical significance of Candida colonization and infection in combat-related injured patients from Iraq and Afghanistan. Open Forum Infect Dis. 2014 Dec 16;1(3):ofu109.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Manolakaki D, Velmahos G, Kourkoumpetis T, Chang Y, Alam HB, De Moya MM, Mylonakis E. Candida infection and colonization among trauma patients. Virulence. 2010 Sep–Oct;1(5):367–75.

    Article  PubMed  Google Scholar 

  16. Mathur P, Hasan F, Singh PK, Malhotra R, Walia K, Chowdhary A. Five-year profile of candidaemia at an Indian trauma centre: High rates of Candida auris blood stream infections. Mycoses. 2018 Sep;61(9):674–80.

    Article  CAS  PubMed  Google Scholar 

  17. Cruciani M, de Lalla F, Mengoli C. Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: a systematic review and meta-analysis. Intensive Care Med. 2005 Nov;31(11):1479–87. Epub 2005 Sep 20. Review.

    Article  PubMed  Google Scholar 

  18. Guery BP, Arendrup MC, Auzinger G, Azoulay E, Borges Sá M, Johnson EM, Müller E, Putensen C, Rotstein C, Sganga G, Venditti M, Zaragoza Crespo R, Kullberg BJ. Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis. Intensive Care Med. 2009 Jan;35(1):55–62.

    Article  PubMed  Google Scholar 

  19. Deitch EA. Gut-origin sepsis: evolution of a concept. Surgeon. 2012 Dec;10(6):350–6.

    Article  PubMed  PubMed Central  Google Scholar 

  20. MacFie J, O’Boyle C, Mitchell CJ, et al. Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity. Gut. 1999;45:223–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Schweinburg FB, Frank HA, Frank ED, et al. Transmural migration of intestinal bacteria during peritoneal irrigation in uremic dogs. Proc Soc Exp Biol Med. 1949;71:150–3.

    Article  CAS  PubMed  Google Scholar 

  22. Assimakopoulos SF, Triantos C, Thomopoulos K, Fligou F, Maroulis I, Marangos M, Gogos CA. Gut-origin sepsis in the critically ill patient: pathophysiology and treatment. Infection. 2018 Dec;46(6):751–60.

    Article  CAS  PubMed  Google Scholar 

  23. Lu F, Inoue K, Kato J, Minamishima S, Morisaki H. Functions and regulation of lipocalin-2 in gut-origin sepsis: a narrative review. Crit Care. 2019 Aug 2;23(1):269.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Jiang LY, Zhang M, Zhou TE, Yang ZF, Wen LQ, Chang JX. Changes of the immunological barrier of intestinal mucosa in rats with sepsis. World J Emerg Med. 2010;1(2):138–43.

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Orasch C, Marchetti O, Garbino J, Schrenzel J, Zimmerli S, Mühlethaler K, Pfyffer G, Ruef C, Fehr J, Zbinden R, Calandra T, Bille J. FUNGINOS. Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland. Clin Microbiol Infect. 2014 Jul;20(7):698–705.

    Article  CAS  PubMed  Google Scholar 

  26. Lilly EA, Ikeh M, Nash EE, Fidel PL Jr, Noverr MC. Immune protection against lethal fungal-bacterial intra-abdominal infections. MBio. 2018 Jan 16;9(1):e01472–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Arendrup MC. Candida and candidaemia. Susceptibility and epidemiology. Dan Med J. 2013 Nov;60(11):B4698.

    PubMed  Google Scholar 

  28. Amornphimoltham P, Yuen PST, Star RA, Leelahavanichkul A. Gut leakage of fungal-derived inflammatory mediators: part of a gut-liver-kidney axis in bacterial sepsis. Dig Dis Sci. 2019 Sep;64(9):2416–28.

    Article  CAS  PubMed  Google Scholar 

  29. Khatib R, Johnson LB, Fakih MG, Riederer K, Briski L. Current trends in candidemia and species distribution among adults: Candida glabrata surpasses C. albicans in diabetic patients and abdominal sources. Mycoses. 2016 Dec;59(12):781–6.

    Article  PubMed  Google Scholar 

  30. Albac S, Schmitz A, Lopez-Alayon C, d’Enfert C, Sautour M, Ducreux A, Labruère-Chazal C, Laue M, Holland G, Bonnin A, Dalle F. Candida albicans is able to use M cells as a portal of entry across the intestinal barrier in vitro. Cell Microbiol. 2016 Feb;18(2):195–210.

    Article  CAS  PubMed  Google Scholar 

  31. Cheng S, Clancy CJ, Xu W, Schneider F, Hao B, Mitchell AP, Nguyen MH. Profiling of Candida albicans gene expression during intra-abdominal candidiasis identifies biologic processes involved in pathogenesis. J Infect Dis. 2013 Nov 1;208(9):1529–37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Kronen R, Liang SY, Bochicchio G, Bochicchio K, Powderly WG, Spec A. Invasive fungal infections secondary to traumatic injury. Int J Infect Dis. 2017 Sep;62:102–11.

    Article  PubMed  Google Scholar 

  33. Rasilainen SK, Juhani MP, Kalevi LA. Microbial colonization of open abdomen in critically ill surgical patients. World J Emerg Surg. 2015 Jun 25;10:25.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Jabra-Rizk MA, Kong EF, Tsui C, Nguyen MH, Clancy CJ, Fidel PL Jr, Noverr M. Candida albicans pathogenesis: fitting within the host-microbe damage response framework. Infect Immun. 2016 Sep 19;84(10):2724–39.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Montravers P, Blot S, Dimopoulos G, Eckmann C, Eggimann P, Guirao X, Paiva JA, Sganga G, De Waele J. Therapeutic management of peritonitis: a comprehensive guide for intensivists. Intensive Care Med. 2016 Aug;42(8):1234–47.

    Article  CAS  PubMed  Google Scholar 

  36. Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA, Rangel-Frausto MS, Rinaldi MG, Saiman L, Wiblin RT, Wenzel RP. National Epidemiology of Mycoses Survey (NEMIS) study group: risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis. 2001;33:177–86.

    Article  CAS  PubMed  Google Scholar 

  37. Rajendran R, Sherry L, Deshpande A, Johnson EM, Hanson MF, Williams C, Munro CA, Jones BL, Ramage G. A prospective surveillance study of candidaemia: epidemiology, risk factors, antifungal treatment and outcome in hospitalized patients. Front Microbiol. 2016 Jun 16;7:915.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Eggimann P, Bille J, Marchetti O. Diagnosis of invasive candidiasis in the ICU. Ann Intensive Care. 2011 Sep 1;1:37.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Sandven P, Qvist H, Skovlund E, Giercksky KE. NORGAS Group and the Norwegian Yeast Study Group. Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations. Crit Care Med. 2002 Mar;30(3):541–7.

    Article  PubMed  Google Scholar 

  40. de Ruiter J, Weel J, Manusama E, Kingma WP, van der Voort PH. The epidemiology of intra-abdominal flora in critically ill patients with secondary and tertiary abdominal sepsis. Infection. 2009 Dec;37(6):522–7.

    Article  PubMed  Google Scholar 

  41. León C, Alvarez-Lerma F, Ruiz-Santana S, León MA, Nolla J, Jordá R, Saavedra P, Palomar M, EPCAN Study Group. Fungal colonization and/or infection in non-neutropenic critically ill patients: results of the EPCAN observational study. Eur J Clin Microbiol Infect Dis. 2009 Mar;28(3):233–42.

    Article  PubMed  Google Scholar 

  42. Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, O’Neill PJ, Chow AW, Dellinger EP, Eachempati SR, Gorbach S, Hilfiker M, May AK, Nathens AB, Sawyer RG, Bartlett JG. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis. 2010 Jan 15;50(2):133–64.

    Article  PubMed  CAS  Google Scholar 

  43. Solomkin JS. Pathogenesis and management of Candida infection syndromes in non-neutropenic patients. New Horiz. 1993 May;1(2):202–13. Review.

    CAS  PubMed  Google Scholar 

  44. Solomkin JS, Flohr AB, Quie PG, Simmons RL. The role of Candida in intraperitoneal infections. Surgery. 1980 Oct;88(4):524–30.

    CAS  PubMed  Google Scholar 

  45. Eggimann P, Pittet D. Candida colonization index and subsequent infection in critically ill surgical patients: 20 years later. Intensive Care Med. 2014 Oct;40(10):1429–48.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Khanna K, Yi PH, Sing DC, Geiger E, Metz LN. Hypoalbuminemia is associated with septic revisions after primary surgery and postoperative infection after revision surgery. Spine (Phila Pa 1976). 2018 Mar 15;43(6):454–60.

    Article  Google Scholar 

  47. de Luis DA, Culebras JM, Aller R, Eiros-Bouza JM. Surgical infection and malnutrition. Nutr Hosp. 2014 Sep 1;30(3):509–13.

    PubMed  Google Scholar 

  48. McCall ME, Adamo A, Latko K, Rieder AK, Durand N, Nathanson T. Maximizing nutrition support practice and measuring adherence to nutrition support guidelines in a Canadian tertiary care ICU. J Intensive Care Med. 2018 Mar;33(3):209–17.

    Article  PubMed  Google Scholar 

  49. Cahill NE, Dhaliwal R, Day AG, Jiang X, Heyland DK. Nutrition therapy in the critical care setting: what is “best achievable” practice? An international multicenter observational study. Crit Care Med. 2010 Feb;38(2):395–401.

    Article  CAS  PubMed  Google Scholar 

  50. Kizilarslanoglu MC, Kuyumcu ME, Yesil Y, Halil M. Sarcopenia in critically ill patients. J Anesth. 2016 Oct;30(5):884–90.

    Article  PubMed  Google Scholar 

  51. Weimann A, Braga M, Carli F, Higashiguchi T, Hübner M, Klek S, Laviano A, Ljungqvist O, Lobo DN, Martindale R, Waitzberg DL, Bischoff SC, Singer P. ESPEN guideline: clinical nutrition in surgery. Clin Nutr. 2017 Jun;36(3):623–50.

    Article  PubMed  Google Scholar 

  52. Braga M, Ljungqvist O, Soeters P, Fearon K, Weimann A, Bozzetti F. ESPEN guidelines on parenteral nutrition: surgery. Clin Nutr. 2009 Aug;28(4):378–86.

    Article  CAS  PubMed  Google Scholar 

  53. Livingston A, Seamons C, Dalton T. If the gut works use it. Nurs Manage. 2000 May;31(5):39–42.

    Article  CAS  PubMed  Google Scholar 

  54. Yamashiro Y. Gut microbiota in health and disease. Ann Nutr Metab. 2017;71(3–4):242–6.

    Article  CAS  PubMed  Google Scholar 

  55. Sam QH, Chang MW, Chai LY. The fungal mycobiome and its interaction with gut bacteria in the host. Int J Mol Sci. 2017 Feb 4;18(2):330.

    Article  PubMed Central  CAS  Google Scholar 

  56. Hostetter MK. Handicaps to host defense. Effects of hyperglycemia on C3 and Candida albicans. Diabetes. 1990 Mar;39(3):271–5. Review.

    Article  CAS  PubMed  Google Scholar 

  57. Bader MS, Hinthorn D, Lai SM, Ellerbeck EF. Hyperglycaemia and mortality of diabetic patients with candidaemia. Diabet Med. 2005 Sep;22(9):1252–7.

    Article  CAS  PubMed  Google Scholar 

  58. Bader MS, Lai SM, Kumar V, Hinthorn D. Candidemia in patients with diabetes mellitus: epidemiology and predictors of mortality. Scand J Infect Dis. 2004;36(11–12):860–4.

    Article  PubMed  Google Scholar 

  59. Rodrigues CF, Rodrigues ME, Henriques M. Candida sp. infections in patients with diabetes mellitus. J Clin Med. 2019 Jan 10;8(1):76.

    Article  CAS  PubMed Central  Google Scholar 

  60. Shahin J, Allen EJ, Patel K, Muskett H, Harvey SE, Edgeworth J, Kibbler CC, Barnes RA, Biswas S, Soni N, Rowan KM, Harrison DA. FIRE study investigators. Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in United Kingdom critical care units. BMC Infect Dis. 2016 Sep 9;16:480.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Sganga G, Bianco G, Fiori B, Nure E, Spanu T, Lirosi MC, Frongillo F, Agnes S. Surveillance of bacterial and fungal infections in the postoperative period following liver transplantation: a series from 2005–2011. Transplant Proc. 2013 Sep;45(7):2718–21.

    Article  CAS  PubMed  Google Scholar 

  62. Muskett H, Shahin J, Eyres G, Harvey S, Rowan K, Harrison D. Risk factors for invasive fungal disease in critically ill adult patients: a systematic review. Crit Care. 2011;15(6):R287.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Leroy O, Gangneux JP, Montravers P, Mira JP, Gouin F, Sollet JP, Carlet J, Reynes J, Rosenheim M, Regnier B, Lortholary O, AmarCand Study Group. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005–2006). Crit Care Med. 2009 May;37(5):1612–8.

    Article  PubMed  Google Scholar 

  64. Sganga G, Bianco G, Frongillo F, Lirosi MC, Nure E, Agnes S. Fungal infections after liver transplantation: incidence and outcome. Transplant Proc. 2014 Sep;46(7):2314–8.

    Article  CAS  PubMed  Google Scholar 

  65. Bassetti M, Peghin M, Carnelutti A, Righi E, Merelli M, Ansaldi F, Trucchi C, Alicino C, Sartor A, Wauters J, Lagrou K, Tascini C, Menichetti F, Mesini A, De Rosa FG, Lagunes L, Rello J, Colombo AL, Vena A, Munoz P, Tumbarello M, Sganga G, Martin-Loeches I, Viscoli C. Invasive candida infections in liver transplant recipients: clinical features and risk factors for mortality. Transplant Direct. 2017 Apr 18;3(5):e156.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Yang Y, Guo F, Kang Y, Zang B, Cui W, Qin B, Qin Y, Fang Q, Qin T, Jiang D, Cai B, Li R, Qiu H, China-SCAN Team. Epidemiology, clinical characteristics, and risk factors for mortality of early- and late-onset invasive candidiasis in intensive care units in China. Medicine (Baltimore). 2017 Oct;96(42):e7830.

    Article  Google Scholar 

  67. Massou S, Ahid S, Azendour H, Bensghir M, Mounir K, Iken M, Lmimouni BE, Balkhi H, Drissi Kamili N, Haimeur C. Systemic candidiasis in medical intensive care unit: analysis of risk factors and the contribution of colonization index. Pathol Biol (Paris). 2013 Jun;61(3):108–12.

    Article  CAS  Google Scholar 

  68. Playford EG, Lipman J, Jones M, Lau AF, Kabir M, Chen SC, Marriott DJ, Seppelt I, Gottlieb T, Cheung W, Iredell JR, McBryde ES, Sorrell TC. Problematic dichotomization of risk for Intensive Care Unit (ICU)-acquired invasive candidiasis: results using a risk-predictive model to categorize 3 levels of risk from a multicenter prospective cohort of Australian ICU patients. Clin Infect Dis. 2016 Dec 1;63(11):1463–9.

    Article  PubMed  Google Scholar 

  69. Guo F, Yang Y, Kang Y, Zang B, Cui W, Qin B, Qin Y, Fang Q, Qin T, Jiang D, Li W, Gu Q, Zhao H, Liu D, Guan X, Li J, Ma X, Yu K, Chan D, Yan J, Tang Y, Liu W, Li R, Qiu H. China-SCAN team invasive candidiasis in intensive care units in China: a multicentre prospective observational study. J Antimicrob Chemother. 2013 Jul;68(7):1660–8.

    Article  CAS  PubMed  Google Scholar 

  70. Clancy CJ, Nguyen MH. Diagnosing invasive candidiasis. J Clin Microbiol. 2018 Apr 25;56(5):e01909–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Clancy CJ, Nguyen MH. Non-culture diagnostics for invasive candidiasis: promise and unintended consequences. J Fungi (Basel). 2018 Feb 19;4(1):27.

    Article  CAS  Google Scholar 

  72. McCarty TP, Pappas PG. Invasive candidiasis. Infect Dis Clin North Am. 2016 Mar;30(1):103–24.

    Article  PubMed  Google Scholar 

  73. Antinori S, Milazzo L, Sollima S, Galli M, Corbellino M. Candidemia and invasive candidiasis in adults: a narrative review. Eur J Intern Med. 2016 Oct;34:21–8.

    Article  PubMed  Google Scholar 

  74. Pitarch A, Nombela C, Gil C. Diagnosis of invasive candidiasis: from gold standard methods to promising leading-edge technologies. Curr Top Med Chem. 2018;18(16):1375–92.

    Article  CAS  PubMed  Google Scholar 

  75. Backx M, White PL, Barnes RA. New fungal diagnostics. Br J Hosp Med (Lond). 2014 May;75(5):271–6.

    Article  CAS  Google Scholar 

  76. Pagès A, Iriart X, Molinier L, Georges B, Berry A, Massip P, Juillard-Condat B. Cost effectiveness of candida polymerase chain reaction detection and empirical antifungal treatment among patients with suspected fungal peritonitis in the intensive care unit. Value Health. 2017 Dec;20(10):1319–28.

    Article  PubMed  Google Scholar 

  77. Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016 Feb 15;62(4):e1–50.

    Article  PubMed  Google Scholar 

  78. Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, Meersseman W, Akova M, Arendrup MC, Arikan-Akdagli S, Bille J, Castagnola E, Cuenca-Estrella M, Donnelly JP, Groll AH, Herbrecht R, Hope WW, Jensen HE, Lass-Flörl C, Petrikkos G, Richardson MD, Roilides E, Verweij PE, Viscoli C, Ullmann AJ, ESCMID Fungal Infection Study Group. ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect. 2012 Dec;18(Suppl 7):19–37.

    Article  CAS  PubMed  Google Scholar 

  79. Dupont H, Paugam-Burtz C, Muller-Serieys C, Fierobe L, Chosidow D, Marmuse JP, Mantz J, Desmonts JM. Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients. Arch Surg. 2002 Dec;137(12):1341–6.

    Article  PubMed  Google Scholar 

  80. Dupont H, Mahjoub Y, Chouaki T, Lorne E, Zogheib E. Antifungal prevention of systemic candidiasis in immunocompetent ICU adults: systematic review and meta-analysis of clinical trials. Crit Care Med. 2017 Nov;45(11):1937–45.

    Article  PubMed  Google Scholar 

  81. León C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez-Lerma F, Garnacho-Montero J, León MA, EPCAN Study Group. A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med. 2006 Mar;34(3):730–7.

    Article  PubMed  Google Scholar 

  82. León C, Ruiz-Santana S, Saavedra P, Galván B, Blanco A, Castro C, Balasini C, Utande-Vázquez A, González de Molina FJ, Blasco-Navalproto MA, López MJ, Charles PE, Martín E, Hernández-Viera MA, Cava Study Group. Usefulness of the “Candida score” for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med. 2009 May;37(5):1624–33.

    Article  PubMed  Google Scholar 

  83. Calandra T, Roberts JA, Antonelli M, Bassetti M, Vincent JL. Diagnosis and management of invasive candidiasis in the ICU: an updated approach to an old enemy. Crit Care. 2016 May 27;20(1):125.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Novy E, Laithier FX, Machouart MC, Albuisson E, Guerci P, Losser MR. Determination of 1,3-β-D-glucan in the peritoneal fluid for the diagnosis of intra-abdominal candidiasis in critically ill patients: a pilot study. Minerva Anestesiol. 2018 Dec;84(12):1369–76.

    Article  PubMed  Google Scholar 

  85. León C, Ruiz-Santana S, Saavedra P, Castro C, Loza A, Zakariya I, Úbeda A, Parra M, Macías D, Tomás JI, Rezusta A, Rodríguez A, Gómez F, Martín-Mazuelos E, Cava Trem Study Group. Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions. Crit Care. 2016 May 16;20(1):149.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Nguyen MH, Wissel MC, Shields RK, Salomoni MA, Hao B, Press EG, Shields RM, Cheng S, Mitsani D, Vadnerkar A, Silveira FP, Kleiboeker SB, Clancy CJ. Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin Infect Dis. 2012 May;54(9):1240–8.

    Article  CAS  PubMed  Google Scholar 

  87. Alam FF, Mustafa AS, Khan ZU. Comparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia. BMC Infect Dis. 2007 Sep 4;7:103.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  88. Sartelli M, Chichom-Mefire A, Labricciosa FM, Hardcastle T, Abu-Zidan FM, Adesunkanmi AK, Ansaloni L, et al. The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections. World J Emerg Surg. 2017 Jul 10;12:29.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Scudeller L, Viscoli C, Menichetti F, del Bono V, Cristini F, Tascini C, Bassetti M, Viale P, ITALIC Group. An Italian consensus for invasive candidiasis management (ITALIC). Infection. 2014 Apr;42(2):263–79.

    Article  CAS  PubMed  Google Scholar 

  90. Sartelli M, Weber DG, Ruppé E, Bassetti M, Wright BJ, Ansaloni L, Catena F, Coccolini F, et al. Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA). World J Emerg Surg. 2016 Jul 15;11:33.

    Article  PubMed  PubMed Central  Google Scholar 

  91. Vergidis P, Clancy CJ, Shields RK, Park SY, Wildfeuer BN, Simmons RL, Nguyen MH. Intra-abdominal candidiasis: the importance of early source control and antifungal treatment. PLoS One. 2016 Apr 28;11(4):e0153247.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  92. Bassetti M, Marchetti M, Chakrabarti A, Colizza S, Garnacho-Montero J, Kett DH, Munoz P, Cristini F, Andoniadou A, Viale P, Rocca GD, Roilides E, Sganga G, Walsh TJ, Tascini C, Tumbarello M, Menichetti F, Righi E, Eckmann C, Viscoli C, Shorr AF, Leroy O, Petrikos G, De Rosa FG. A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. Intensive Care Med. 2013 Dec;39(12):2092–106.

    Article  PubMed  Google Scholar 

  93. Lagunes L, Borgatta B, Martín-Gomez MT, Rey-Pérez A, Antonelli M, Righi E, Merelli M, Brugnaro P, Dimopoulos G, Garnacho-Montero J, Colombo AL, Luzzati R, Menichetti F, Muñoz P, Nucci M, Scotton G, Viscoli C, Tumbarello M, Bassetti M, Rello J, IAC Study Investigators. Predictors of choice of initial antifungal treatment in intraabdominal candidiasis. Clin Microbiol Infect. 2016 Aug;22(8):719–24.

    Article  CAS  PubMed  Google Scholar 

  94. Benoist H, Rodier S, de La Blanchardière A, Bonhomme J, Cormier H, Thibon P, Saint-Lorant G. Appropriate use of antifungals: impact of an antifungal stewardship program on the clinical outcome of candidaemia in a French University Hospital. Infection. 2019 Jun;47(3):435–40.

    Article  CAS  PubMed  Google Scholar 

  95. O’Leary RA, Einav S, Leone M, Madách K, Martin C, Martin-Loeches I. Management of invasive candidiasis and candidaemia in critically ill adults: expert opinion of the European Society of Anaesthesia Intensive Care Scientific Subcommittee. J Hosp Infect. 2018 Apr;98(4):382–90.

    Article  PubMed  Google Scholar 

  96. Sganga G, Wang M, Capparella MR, Tawadrous M, Yan JL, Aram JA, Montravers P. Evaluation of anidulafungin in the treatment of intra-abdominal candidiasis: a pooled analysis of patient-level data from 5 prospective studies. Eur J Clin Microbiol Infect Dis. 2019 Jul 6;38(10):1849–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016 Feb 15;62(4):e1–50.

    Article  PubMed  Google Scholar 

  98. Guery BP, Arendrup MC, Auzinger G, Azoulay E, Borges Sá M, Johnson EM, Müller E, Putensen C, Rotstein C, Sganga G, Venditti M, Zaragoza Crespo R, Kullberg BJ. Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part II. Treat Intensive Care Med. 2009 Feb;35(2):206–14.

    Article  CAS  PubMed  Google Scholar 

  99. Zaragoza R, Pemán J, Salavert M, Viudes A, Solé A, Jarque I, Monte E, Romá E, Cantón E. Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts? Ther Clin Risk Manag. 2008 Dec;4(6):1261–80.

    Article  PubMed  PubMed Central  Google Scholar 

  100. Montagna T, Lovero G, Coretti C, Martinelli D, De Giglio O, Iatta R, Balbino S, Rosato A, Caggiano G. Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods. Montagna BMC Microbiol. 2015 May 20;15:106.

    Article  PubMed  CAS  Google Scholar 

  101. Occhionorelli S, Zese M, Cultrera R, Lacavalla D, Albanese M, Vasquez G. Open abdomen management and candida infections: a very likely link. Gastroenterol Res Pract. 2017;2017:5187620.

    Article  PubMed  PubMed Central  Google Scholar 

  102. Zilberberg M, Yu HT, Chaudhari P, Emons MF, Khandelwal N, Shorr AF. Relationship of fluconazole prophylaxis with fungal microbiology in hospitalized intra-abdominal surgery patients: a descriptive cohort study. Crit Care. 2014 Oct 29;18(5):590.

    Article  PubMed  PubMed Central  Google Scholar 

  103. Lima WG, Alves-Nascimento LA, Andrade JT, Vieira L, de Azambuja Ribeiro RIM, Thomé RG, Dos Santos HB, Ferreira JMS, Soares AC. Are the statins promising antifungal agents against invasive candidiasis? Biomed Pharmacother. 2019 Mar;111:270–81.

    Article  CAS  PubMed  Google Scholar 

  104. Maseda E, Rodríguez-Manzaneque M, Dominguez D, González-Serrano M, Mouriz L, Álvarez-Escudero J, Ojeda N, Sánchez-Zamora P, Granizo JJ, Giménez MJ, Peri-Operative Infection Working Group of the Spanish Society of Anesthesiology and Critical Care (GTIPO-SEDAR). Intraabdominal candidiasis in surgical ICU patients treated with anidulafungin: a multicenter retrospective study. Rev Esp Quimioter. 2016 Feb;29(1):32–9.

    PubMed  Google Scholar 

  105. Pea F, Righi E, Cojutti P, Carnelutti A, Baccarani U, Soardo G, Bassetti M. Intra-abdominal penetration and pharmacodynamic exposure to fluconazole in three liver transplant patients with deep-seated candidiasis. J Antimicrob Chemother. 2014 Sep;69(9):2585–6.

    Article  CAS  PubMed  Google Scholar 

  106. Vincent JL. Microbial resistance: lessons from the EPIC study. European Prevalence of Infection. Intensive Care Med. 2000;26(Suppl 1):S3–8.

    PubMed  Google Scholar 

  107. Olaechea PM, Palomar M, León-Gil C, Alvarez-Lerma F, Jordá R, Nolla-Salas J, León-Regidor MA. EPCAN Study Group Economic impact of Candida colonization and Candida infection in the critically ill patient. Eur J Clin Microbiol Infect Dis. 2004 Apr;23(4):323–30.

    Article  CAS  PubMed  Google Scholar 

  108. Knitsch W, Vincent JL, Utzolino S, François B, Dinya T, Dimopoulos G, Özgüneş İ, Valía JC, Eggimann P, León C, Montravers P, Phillips S, Tweddle L, Karas A, Brown M, Cornely OA. A randomized, placebo-controlled trial of preemptive antifungal therapy for the prevention of invasive candidiasis following gastrointestinal surgery for intra-abdominal infections. Clin Infect Dis. 2015 Dec 1;61(11):1671–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  109. Shields RK, Nguyen MH, Press EG, Clancy CJ. Abdominal candidiasis is a hidden reservoir of echinocandin resistance. Antimicrob Agents Chemother. 2014 Dec;58(12):7601–5.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  110. Dimopoulos G, Paiva JA, Meersseman W, Pachl J, Grigoras I, Sganga G, Montravers P, Auzinger G, Sá MB, Miller PJ, Marček T, Kantecki M, Ruhnke M. Efficacy and safety of anidulafungin in elderly, critically ill patients with invasive Candida infections: a post hoc analysis. Int J Antimicrob Agents. 2012 Dec;40(6):521–6.

    Article  CAS  PubMed  Google Scholar 

  111. Sganga G, Pepe G, Cozza V, Nure E, Lirosi MC, Frongillo F, Grossi U, Bianco G, Agnes S. Anidulafungin—a new therapeutic option for Candida infections in liver transplantation. Transplant Proc. 2012 Sep;44(7):1982–5.

    Article  CAS  PubMed  Google Scholar 

  112. Ruhnke M, Paiva JA, Meersseman W, Pachl J, Grigoras I, Sganga G, Menichetti F, Montravers P, Auzinger G, Dimopoulos G, Borges Sá M, Miller PJ, Marček T, Kantecki M. Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients. Clin Microbiol Infect. 2012 Jul;18(7):680–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  113. Xie GH, Fang XM, Fang Q, Wu XM, Jin YH, Wang JL, Guo QL, Gu MN, Xu QP, Wang DX, Yao SL, Yuan SY, Du ZH, Sun YB, Wang HH, Wu SJ, Cheng BL. Impact of invasive fungal infection on outcomes of severe sepsis: a multicenter matched cohort study in critically ill surgical patients. Crit Care. 2008;12(1):R5.

    Article  PubMed  PubMed Central  Google Scholar 

  114. Almirante B, Rodríguez D, Park BJ, Cuenca-Estrella M, Planes AM, Almela M, Mensa J, Sanchez F, Ayats J, Gimenez M, Saballs P, Fridkin SK, Morgan J, Rodriguez-Tudela JL, Warnock DW, Pahissa A. Barcelona Candidemia Project Study Group: Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003. J Clin Microbiol. 2005;43:1829–235.

    Article  PubMed  PubMed Central  Google Scholar 

  115. Raymond DP, Pelletier SJ, Crabtree TD, Gleason TG, Pruett TL, Sawyer RG. Impact of bloodstream infection on outcomes among infected surgical inpatients. Ann Surg. 2001;233:549–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  116. Maseda E, Rodríguez-Manzaneque M, Dominguez D, González-Serrano M, Mouriz L, Álvarez-Escudero J, Ojeda N, Sánchez-Zamora P, Granizo JJ, Giménez MJ, Peri-Operative Infection Working Group of the Spanish Society of Anesthesiology and Critical Care (GTIPO-SEDAR). Intraabdominal candidiasis in surgical ICU patients treated with anidulafungin: a multicenter retrospective study. Rev Esp Quimioter. 2016 Feb;29(1):32–9.

    PubMed  Google Scholar 

  117. Choi H, Kim JH, Seong H, Lee W, Jeong W, Ahn JY, Jeong SJ, Ku NS, Yeom JS, Kim YK, Kim HY, Song YG, Kim JM, Choi JY. Changes in the utilization patterns of antifungal agents, medical cost and clinical outcomes of candidemia from the health-care benefit expansion to include newer antifungal agents. Int J Infect Dis. 2019 Jun;83:49–55.

    Article  PubMed  Google Scholar 

  118. Heimann SM, Cornely OA, Wisplinghoff H, Kochanek M, Stippel D, Padosch SA, Langebartels G, Reuter H, Reiner M, Vierzig A, Seifert H, Vehreschild MJ, Glossmann J, Franke B, Vehreschild JJ. Candidemia in the intensive care unit: analysis of direct treatment costs and clinical outcome in patients treated with echinocandins or fluconazole. Eur J Clin Microbiol Infect Dis. 2015 Feb;34(2):331–8.

    Article  CAS  PubMed  Google Scholar 

  119. Lortholary O, Renaudat C, Sitbon K, Madec Y, Denoeud-Ndam L, Wolff M, Fontanet A, Bretagne S, Dromer F, French Mycosis Study Group. Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002–2010). Intensive Care Med. 2014 Sep;40(9):1303–12.

    Article  PubMed  PubMed Central  Google Scholar 

  120. Puig-Asensio M, Pemán J, Zaragoza R, Garnacho-Montero J, Martín-Mazuelos E, Cuenca-Estrella M, Almirante B, Prospective Population Study on Candidemia in Spain (CANDIPOP) Project, Hospital Infection Study Group (GEIH), Medical Mycology Study Group (GEMICOMED) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Spanish Network for Research in Infectious Diseases. Impact of therapeutic strategies on the prognosis of candidemia in the ICU. Crit Care Med. 2014 Jun;42(6):1423–32.

    Article  CAS  PubMed  Google Scholar 

  121. Auzinger G, Playford EG, Graham CN, Knox HN, Weinstein D, Kantecki M, Schlamm H, Charbonneau C. Cost-effectiveness analysis of anidulafungin for the treatment of candidaemia and other forms of invasive candidiasis. BMC Infect Dis. 2015 Oct 26;15:463.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  122. Murri R, Scoppettuolo G, Ventura G, Fabbiani M, Giovannenze F, Taccari F, Milozzi E, Posteraro B, Sanguinetti M, Cauda R, Fantoni M. Initial antifungal strategy does not correlate with mortality in patients with candidemia. Eur J Clin Microbiol Infect Dis. 2016 Feb;35(2):187–93.

    Article  CAS  PubMed  Google Scholar 

  123. Tadec L, Talarmin JP, Gastinne T, Bretonnière C, Miegeville M, Le Pape P, Morio F. Epidemiology, risk factor, species distribution, antifungal resistance and outcome of candidemia at a single French hospital: a 7-year study. Mycoses. 2016 May;59(5):296–303.

    Article  PubMed  Google Scholar 

  124. Garnacho-Montero J, Díaz-Martín A, Cantón-Bulnes L, Ramírez P, Sierra R, Arias-Verdú D, Rodríguez-Delgado M, Loza-Vázquez A, Rodriguez-Gomez J, Gordón M, Estella Á, García-Garmendia JL. Initial antifungal strategy reduces mortality in critically ill patients with candidemia: a propensity score-adjusted analysis of a multicenter study. Crit Care Med. 2018 Mar;46(3):384–93.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sganga Gabriele .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gabriele, S., Pietro, F., Gilda, P., Marta, D.G., Valerio, C. (2021). Invasive Candidiasis in Surgical Patients. In: Sartelli, M., Coimbra, R., Pagani, L., Rasa, K. (eds) Infections in Surgery. Hot Topics in Acute Care Surgery and Trauma. Springer, Cham. https://doi.org/10.1007/978-3-030-62116-2_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-62116-2_20

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-62115-5

  • Online ISBN: 978-3-030-62116-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics